An improved LC-MS/MS method for quantitative determination of metolazone in human plasma and its application to a pharmacokinetic study

Biomed Chromatogr. 2011 Oct;25(10):1138-43. doi: 10.1002/bmc.1583. Epub 2011 Mar 9.

Abstract

A simple, rapid and accurate liquid chromatography-tandem mass spectrometry method has been developed. After a liquid-liquid extraction procedure, samples were chromatographed on an Agilent TC-C(18) (150 × 4.6 mm, 5 μm) column using an isocratic elution mobile phase composed of methanol and distilled water (70:30, v/v) at a flow rate of 0.5 mL/min. After single-dose administration of 0.5, 1 and 2 mg metolazone, the t(1/2) values were 6.6 ± 2.8, 7.9 ± 1.2 and 7.6 ± 1.9 h, respectively. The pharmacokinetic parameters of multiple doses (1 mg metolazone) were as follows: t(1/2) was 8.9 ± 1.0 h; C(max) was 22.4 ± 5.0 ng/mL; and AUC(0-48) was 156.8 ± 31.6 ng h/mL.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Area Under Curve
  • Chromatography, Liquid / methods*
  • Drug Stability
  • Female
  • Humans
  • Least-Squares Analysis
  • Male
  • Methanol / chemistry
  • Metolazone / administration & dosage
  • Metolazone / blood*
  • Metolazone / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • Metolazone
  • Methanol